New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB
TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid. Read Here.
top of page
Recent Posts
See AllThe Curry International Tuberculosis Center (CITC) proudly announces the online release of 2022 updates to the 3rd edition of its highly acclaimed guide, Drug-Resistant Tuberculosis: A Survival Guide
120
The World Health Organization (WHO) has just released updated consolidated guidelines on the treatment of drug-resistant TB (DR-TB) featuring major improvements in treatment options for people with mu
140
Viatris, a global healthcare company, MedAccess, and TB Alliance have announced a new agreement to reduce the price of pretomanid, a drug used to treat multidrug-resistant tuberculosis, by 34%. Pretom
160
bottom of page